| Product Code: ETC6661401 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Monkeypox Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Monkeypox Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Monkeypox Market - Industry Life Cycle |
3.4 Canada Monkeypox Market - Porter's Five Forces |
3.5 Canada Monkeypox Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Canada Monkeypox Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.7 Canada Monkeypox Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Monkeypox Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about monkeypox in Canada |
4.2.2 Growing investments in research and development for monkeypox treatments |
4.2.3 Rising demand for effective prevention and control measures for monkeypox |
4.3 Market Restraints |
4.3.1 Limited availability of specific treatments for monkeypox in the Canadian market |
4.3.2 Stringent regulations and policies related to the import and export of monkeypox-related products |
5 Canada Monkeypox Market Trends |
6 Canada Monkeypox Market, By Types |
6.1 Canada Monkeypox Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Canada Monkeypox Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Canada Monkeypox Market Revenues & Volume, By Cidofovir, 2021- 2031F |
6.1.4 Canada Monkeypox Market Revenues & Volume, By Brincidofovir, 2021- 2031F |
6.1.5 Canada Monkeypox Market Revenues & Volume, By Tecovirimat, 2021- 2031F |
6.1.6 Canada Monkeypox Market Revenues & Volume, By Vaccinia ImmuneGlobulin, 2021- 2031F |
6.2 Canada Monkeypox Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 Canada Monkeypox Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.3 Canada Monkeypox Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 Canada Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Monkeypox Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Monkeypox Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.3.3 Canada Monkeypox Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.4 Canada Monkeypox Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Canada Monkeypox Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.6 Canada Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Monkeypox Market Import-Export Trade Statistics |
7.1 Canada Monkeypox Market Export to Major Countries |
7.2 Canada Monkeypox Market Imports from Major Countries |
8 Canada Monkeypox Market Key Performance Indicators |
8.1 Number of reported monkeypox cases in Canada |
8.2 Percentage of healthcare professionals trained in monkeypox management |
8.3 Funding allocated towards monkeypox research and development |
9 Canada Monkeypox Market - Opportunity Assessment |
9.1 Canada Monkeypox Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Canada Monkeypox Market Opportunity Assessment, By End users, 2021 & 2031F |
9.3 Canada Monkeypox Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Monkeypox Market - Competitive Landscape |
10.1 Canada Monkeypox Market Revenue Share, By Companies, 2024 |
10.2 Canada Monkeypox Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here